Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-19 of 19
1-19 of 19
Filter
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Mike Sandoval
President at Sante Laboratories
accuracy and precision, analytical chemistry, aspergillosis, bank, bioavailability, brand, breakfast, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemical substance, chemistry, competition, consumer protection, conversation, crystallization, cytochrome p450, diclofenac, dietary supplement, distillation, dose (biochemistry), dream, drug development, due diligence, electronic cigarette, emulsion, endocannabinoid system, experiment, expert, expungement, food and drug administration, frosted mini-wheats, health, human, humidity, ibuprofen, immunodeficiency, infection, information, insurance, investor, laboratory, loan, market (economics), medical cannabis, memory, mold, money, mycotoxin, occupational safety and health, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, ph meter, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, reason, regulatory compliance, route of administration, safety, scientific method, sesame, shelf life, sleep, solution, stove, tablet (pharmacy), technology, temperature, tetrahydrocannabinol, the matrix, traceability, tractor, transparency and translucency, treaty, understanding
Marcus Najera
Founder at Cannabis Science Talk
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, dose (biochemistry), emotion, enzyme, hash oil, liposome, memory, micelle, milk, nanotechnology, neuroimaging, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol
Jackson Rowland
CEO at Green Genomix
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, dose (biochemistry), emotion, enzyme, hash oil, liposome, memory, micelle, milk, nanotechnology, neuroimaging, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol
Carter Baird
R&D Laboratory Technician at United Cannabis Corporation
absorption (pharmacology), alternative medicine, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), chemist, concussion, crohn's disease, cytochrome p450, dose (biochemistry), drink, emotion, endocannabinoid system, entourage effect, enzyme, gpr55, hash oil, immune system, immunodeficiency, liposome, liquor, memory, micelle, milk, moonshine, nanotechnology, neuroimaging, neuron, pharmaceutical industry, pharmacokinetics, pharmacology, prohibition, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol, weight training
Chris Denicola
CEO & Co-Founder at Prism Science and Santeer
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, dose (biochemistry), emotion, enzyme, hash oil, liposome, memory, micelle, milk, nanotechnology, neuroimaging, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol
Emek Blair
Founder and Chief Scientist at Puffin Hemp
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chemist, clinical trial, concussion, cytochrome p450, dietary supplement, disease, dose (biochemistry), drug overdose, emergency department, emotion, enzyme, food, hash oil, heroin, liposome, medical cannabis, medication, memory, micelle, milk, nanotechnology, neuroimaging, neurology, neurosurgery, nicotine, opioid overdose, pharmaceutical industry, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, surgery, tetrahydrocannabinol, therapy
Kevin Schmidt
Director of Research & Development at Centuria Foods
absorption (pharmacology), adele, android (operating system), ann arbor, michigan, bank of america, bioavailability, blood sugar level, california, canada, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, debate, dose (biochemistry), dvd, emotion, enzyme, hash oil, heavy metal music, ice cream, illinois, liposome, memory, micelle, michael jackson, microphone, milk, muhammad ali, nanotechnology, neuroimaging, new york city, news, ohio, pharmacokinetics, psalms, receptor (biochemistry), receptor antagonist, reggae, snow removal, spotify, surfactant, tetrahydrocannabinol, united states
Kevin Koby
Chief Scientific Officer at Abstrax Tech
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, breathing, cannabinoid, cannabis, chylomicron, cytochrome p450, digestion, dose (biochemistry), drug test, enzyme, intravenous therapy, medical cannabis, medication, medicine, pharmacogenomics, pharmacokinetics, physician, science, tetrahydrocannabinol, vaporizer (inhalation device)
Steven Bennett
Founder and Chief Scientific Officer at Prescott Logic Technologies Ltd.
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, brand, breathing, business model, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, classified information, clinical trial, conversation, cytochrome p450, digestion, dose (biochemistry), drug, drug test, enzyme, facebook, food and drug administration, hashish, hemp, instagram, intravenous therapy, intrinsic safety, lobbying in the united states, market (economics), marketplace, median lethal dose, medical cannabis, medical prescription, medication, medicine, nutraceutical, over-the-counter drug, pepsi, pharmacogenomics, pharmacokinetics, pharmacology, physician, prescription drug, pressure vessel, reality, receptor (biochemistry), receptor antagonist, reputation, retail, science, shelf life, shore durometer, social media, tax, tetrahydrocannabinol, theory, understanding, vaporizer (inhalation device), washing machine, word-of-mouth marketing, xfinity
A.J. Herrington
Freelance Writer at High Times, Merry Jane, Sensi, HEMP
alternative medicine, amphetamine, animal testing, antioxidant, attention deficit hyperactivity disorder, bioavailability, breathing, cannabinoid, cannabis, chylomicron, cytochrome p450, digestion, dose (biochemistry), drug test, enzyme, intravenous therapy, medical cannabis, medication, medicine, pharmacogenomics, pharmacokinetics, physician, science, tetrahydrocannabinol, vaporizer (inhalation device)
David Gordon
Owner at 4 Pillars Health & Wellness
alternative medicine, amphetamine, animal testing, anti-inflammatory, antioxidant, attention deficit hyperactivity disorder, bioavailability, bong, breathing, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, cytochrome p450, digestion, dispensary, dose (biochemistry), drug test, enzyme, intravenous therapy, kentucky, medical cannabis, medical school, medication, medicine, nursing, ondansetron, opiate, over-the-counter drug, pharmacogenomics, pharmacokinetics, physician, prescription drug, psychopharmacology, research, science, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy, vaporizer (inhalation device)
Ricardo E Rivera-Acevedo
Chief Science Officer, Adjunct Professor at Ecovita Health Corporation, University Of British Columbia
alternative medicine, amphetamine, anesthesiology, animal testing, antioxidant, attention deficit hyperactivity disorder, automation, bioavailability, biodegradation, brand, breathing, business ethics, cannabidiol, cannabinoid, cannabinol, cannabis, cell membrane, chylomicron, competition, compost, cytochrome p450, dangerous goods, digestion, dose (biochemistry), drug test, electronic cigarette, engineering, environmental remediation, enzyme, good manufacturing practice, hemp, innovation, intravenous therapy, iso 9000, labeling of fertilizer, liquid-liquid extraction, litter, litter box, medical cannabis, medication, medicine, membrane, nanofiltration, nsf international, pesticide, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, physician, plastic, pressure vessel, recycling, reputation, risk, safety, science, specification (technical standard), tetrahydrocannabinol, traceability, vaporizer (inhalation device), waste, waste management, water, water purification, water treatment
1
1-19 of 19